MLRagent

Shared reference text/digital resource should be authored by demonstrated subject-matter experts

AI-verifiedwarningFDA guidance · non-bindingRaised as a question — a person decides

Rule

A reference text or digital clinical practice resource included in an SIUU communication should be authored, edited, and contributed to by individuals with demonstrated subject-matter expertise (via education or experience).

Check

Check contributor credentials against the subject matter covered. A violation is content authored/edited/contributed to by individuals lacking demonstrated relevant expertise.

Escalate when

Whether the authors, editors and contributors have demonstrated expertise in the relevant subject area through education or experience requires judgment, and contributor credentials may not be disclosed.

Where this comes from

Section V, Q4, item 2.b (Reference Texts / Digital Clinical Practice Resources) · page 27. The highlighted words are quoted exactly; a script confirms they appear in the source before the rule can be published.

This rule is one item of a list. The list is introduced by: FDA recommends that a reference text or material from a digital clinical practice resource have all of the following characteristics if a firm chooses to include it in an SIUU communication:

…ooses to include it in an SIUU communication: It is published by an independent publisher that is in the business of publishing scientific or medical educational content It is published in a manner consistent with current standards for medical content creation and review that are generally accepted by the medical publishing industry and in accordance with any specific peer-review procedures of the publisher It is authored, edited, and contributed to by experts who have demonstrated expertise in the subject area(s) through education or experience It is generally available or sold through independent distribution channels (e.g., internet sources, book retailers, subscriptions, libraries) for medical and scientific educational content Reference texts or material(s) from digital clinical practice resources that misrepresent or overstate findings from a study or analysis in light of the limitations of such study or analysis would not fall within the enforcem…
Document
FDA guidance: Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products: Questions and Answers (final)
Version
as retrieved — the publisher does not version this document; the fingerprint below identifies the exact file
Retrieved
2026-09-21 from www.fda.gov
Fingerprint
a36a07e1efd950b7a2a8f6b3…

FDA guidance describes the agency's current thinking. It is not binding law, and this rule is a recommendation, not an obligation.